Brief: ProPhase Labs Aiming For Commercial Launch Of BE-Smart Test For Esophageal Cancer In H2 2024
10/04/2024 13:20
April 10 (Reuters) - Prophase Labs Inc PRPH.O :
* PROPHASE LABS INC - AIMING FOR COMMERCIAL LAUNCH OF
BE-SMART
TEST FOR ESOPHAGEAL CANCER IN SECOND HALF OF 2024
Source text for Eikon: ID:nGNXbK4Z2S
Further company coverage: PRPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prophase Labs
See all newsBrief: Prophase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 08:29 PM